DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LEUKERAN

« Back to Dashboard

Clinical Trials for Leukeran

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00875667	A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)	Active, not recruiting	Celgene Corporation	Phase 2	To evaluate the safety and efficacy of lenalidomide versus investigator choice in patients with relapsed or refractory Mantle Cell Lymphoma.
NCT00910910	Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)	Active, not recruiting	Celgene Corporation	Phase 3	The purpose of this study is to determine the safety and efficacy of lenalidomide as a first line therapy in treating patients with B-cell Chronic Lymphocytic Leukemia. This study will compare the effects (good and bad) of lenalidomide with chlorambucil.
NCT01088048	Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chron	Completed	Gilead Sciences	Phase 1	This study will evaluate the safety and clinical activity of idelalisib in combination with an anti-CD20 monoclonal antibody (mAb), a chemotherapeutic agent, an mTOR inhibitor, a protease inhibitor, an antiangiogenic agent, and/or an immunomodulatory agent in participants with relapsed or refractory indolent B-cell non-Hodgkin lymphoma (NHL), mantle cell lymphoma (MCL), or chronic lymphocytic leukemia (CLL).

Clinical Trial Conditions for Leukeran

Condition Name

Condition Name for Leukeran
Intervention	Trials
Chronic Lymphocytic Leukemia	3
Mantle Cell Lymphoma	2
Lymphoma, Mantle-Cell	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Leukeran
Intervention	Trials
Leukemia, Lymphoid	5
Leukemia, Lymphocytic, Chronic, B-Cell	5
Leukemia	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Leukeran

Trials by Country

Trials by Country for Leukeran
Location	Trials
United States	61
United Kingdom	20
Brazil	5
Australia	3
Canada	3

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Leukeran
Location	Trials
Washington	3
New York	3
California	3
Texas	3
New Jersey	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Leukeran

Clinical Trial Phase

Clinical Trial Phase for Leukeran
Clinical Trial Phase	Trials
Phase 3	4
Phase 2	1
Phase 1	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Leukeran
Clinical Trial Phase	Trials
Recruiting	2
Active, not recruiting	2
Completed	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Leukeran

Sponsor Name

Sponsor Name for Leukeran
Sponsor	Trials
Celgene Corporation	2
Napp Pharmaceuticals Limited	1
GlaxoSmithKline	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Leukeran
Sponsor	Trials
Industry	8
Other	1

Export unavailable in trial.
Subscribe for complete access.